Ida Stisen Fogh-Andersen, Ingeborg Farver-Vestergaard, Christian Møller Pedersen, Elisabeth Shirin Tehrani & Anders Løkke
Ugeskr Læger 2021;183:V09200679
An estimated 33% of patients with COPD have co-morbidities in terms of anxiety and/or depression (A&D). A large proportion of these patients are not diagnosed, mainly because some of the core symptoms of A&D can be misinterpreted as being caused by COPD. Untreated A&D in patients with COPD can have a negative impact on several parameters e.g. dyspnoea and mortality. On this basis, this review argues, that special focus in primary care and hospitals on diagnosing and treating A&D in patients with COPD using anti-depressants or cognitive therapy can reduce symptom burden and significantly improve quality of life.